Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol + Hydrocortisone in Facial and Intertriginous Psoriasis
NCT00691002Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- May 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of calcipotriol + hydrocortisone in Psoriasis vulgaris (PV), sponsored by LEO Pharma. Started May 2008; status: completed.
02
Drugs
calcipotriol + hydrocortisone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT00691002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691002.